Inhibition of platelet-derived growth factor receptor tyrosine kinase by atrial natriuretic peptide

Medicine & Life Sciences

• PDGF receptor tyrosine kinase 100%
• Atrial Natriuretic Factor 66%
• Platelet-Derived Growth Factor Receptors 44%
• Platelet-Derived Growth Factor 30%
• Protein-Tyrosine Kinases 24%
• HS 142-1 12%
• atrial natriuretic factor receptor B 11%
• 8-bromocyclic GMP 9%
• Cyclic GMP-Dependent Protein Kinases 8%
• Vanadates 8%
• Guanylate Cyclase 8%
• Protein Tyrosine Phosphatases 8%
• Cyclic GMP 7%
• Receptor Protein-Tyrosine Kinases 7%
• Affinity Chromatography 7%
• Lectins 6%
• Vascular Smooth Muscle 6%
• Tyrosine 6%
• Smooth Muscle Myocytes 5%
• Sodium 5%
• Phosphotransferases 5%
• Phosphorylation 4%
• Membranes 3%
• In Vitro Techniques 2%
• Proteins 2%